Pembrolizumab

Category: Cancer

Pembrolizumab Overview

Pembrolizumab (formerly MK-3475 and lambrolizumab, trade name Keytruda)[1] is a humanized antibody used in cancer immunotherapy. It is an IgG4 isotype antibody that blocks a protective mechanism of cancer cells and thereby, allows the immune system to destroy them. It targets the programmed cell death protein 1 (PD-1) receptor of lymphocytes. The FDA initially approved it to treat metastatic melanoma. In 2017 the FDA approved it for any unresectable or metastatic solid tumor w...

Read more Pembrolizumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pembrolizumab

Recent Pembrolizumab Forums:

Possible Dosages for this and Related Drugs:

Other drugs which contain Pembrolizumab or a similar ingredient: (1 result)

• KEYTRUDA Pembrolizumab2 discussions

Related Pembrolizumab Topics: